It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Extensive rodent literature suggests that the endocannabinoid (eCB) system present in the nucleus accumbens (NAc) modulates dopamine (DA) release in this area. However, expression patterns of the cannabinoid receptor type 1 (CB1R), the synthesizing enzyme N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD), and the degradation enzyme fatty acid amide hydrolase (FAAH) in the NAc have not yet been described in non-human primates. The goal of this study is therefore to characterize the expression and localization of the eCB system within the NAc of vervet monkeys (Chlorocebus sabaeus) using Western blots and immunohistochemistry. Results show that CB1R, NAPE-PLD, and FAAH are expressed across the NAc rostrocaudal axis, both in the core and shell. CB1R, NAPE-PLD, and FAAH are localized in medium spiny neurons (MSNs) and fast-spiking GABAergic interneurons (FSIs). Dopaminergic projections and astrocytes did not express CB1R, NAPE-PLD, or FAAH. These data show that the eCB system is present in the vervet monkey NAc and supports its role in the primate brain reward circuit.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 School of Optometry, University of Montreal, Montreal, QC, Canada
2 School of Optometry, University of Montreal, Montreal, QC, Canada; Department of Psychiatry and Human Genetics, McGill University, Montreal, QC, Canada; St‐Kitts Behavioural Science Foundation, West Indies, Caribbean, Saint Kitts and Nevis
3 School of Optometry, University of Montreal, Montreal, QC, Canada; Faculty of Medicine, University of Montreal, Montreal, QC, Canada
4 Laboratory of Neuropsychiatry, Psychiatric Centre Copenhagen, Copenhagen, Denmark
5 Department of Psychiatry and Human Genetics, McGill University, Montreal, QC, Canada; St‐Kitts Behavioural Science Foundation, West Indies, Caribbean, Saint Kitts and Nevis
6 School of Optometry, University of Montreal, Montreal, QC, Canada; St‐Kitts Behavioural Science Foundation, West Indies, Caribbean, Saint Kitts and Nevis; Laboratory of Neuropsychiatry, Psychiatric Centre Copenhagen, Copenhagen, Denmark